Plasma levels of IL‐18 (P < 0.001) and IL‐18BP (P < 0.01), were also elevated in COVID‐19 patients compared to controls at baseline, suggesting increased inflammasome activation (Fig. 1). The gene discussed is IL18; the disease is COVID-19.